This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kohlhuber, F.
Right arrow Articles by Kerr, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kohlhuber, F.
Right arrow Articles by Kerr, I. M.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Feb 1997, 695-706, Vol 17, No. 2
Copyright © 1997, American Society for Microbiology

A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses

F Kohlhuber, NC Rogers, D Watling, J Feng, D Guschin, J Briscoe, BA Witthuhn, SV Kotenko, S Pestka, GR Stark, JN Ihle and IM Kerr
Imperial Cancer Research Fund, London, United Kingdom.

Cell lines that are mutated in interferon (IFN) responses have been critical in establishing an essential role for the JAK family of nonreceptor tyrosine kinases in interferon signalling. Mutant gamma1A cells have previously been shown to be complemented by overexpression of JAK2. Here, it is shown that these cells carry a defect in, and can also be complemented by, the beta-subunit of the IFN-gamma receptor, consistent with the hypothesis that the mutation in these cells affects JAK2-receptor association. In contrast, mutant gamma2A cells lack detectable JAK2 mRNA and protein. By using gamma2A cells, the role of various domains and conserved tyrosine residues of JAK2 in IFN-gamma signalling was examined. Individual mutation of six conserved tyrosine residues, mutation of a potential phosphatase binding site, or mutation of the arginine residue in the proposed SH2-like domain had no apparent effect on signalling in response to IFN-gamma. Results with deletion mutants, however, indicated that association of JAK2 with the IFN- gammaR2 subunit requires the amino-terminal region but not the pseudokinase domain. Consistent with this, in chimeras with JAK1, the JAK2 amino-terminal region was required for receptor association and STAT1 activation. Conversely, a JAK1-JAK2 chimera with the amino- terminal domains of JAK1 linked to the pseudokinase and kinase domains of JAK2 is capable of reconstituting JAK-STAT signalling in response to IFN-alpha and -gamma in mutant U4C cells lacking JAK1. The specificity of the JAKs may therefore lie mainly in their structural interaction with different receptor and signalling proteins rather than in the substrate specificity of their kinase domains.


This article has been cited by other articles:

  • McGillicuddy, F. C., Chiquoine, E. H., Hinkle, C. C., Kim, R. J., Shah, R., Roche, H. M., Smyth, E. M., Reilly, M. P. (2009). Interferon {gamma} Attenuates Insulin Signaling, Lipid Storage, and Differentiation in Human Adipocytes via Activation of the JAK/STAT Pathway. J. Biol. Chem. 284: 31936-31944 [Abstract] [Full Text]  
  • Jiang, L., Li, Z., Rui, L. (2008). Leptin Stimulates Both JAK2-dependent and JAK2-independent Signaling Pathways. J. Biol. Chem. 283: 28066-28073 [Abstract] [Full Text]  
  • Yang, N., Langenheim, J. F., Wang, X., Jiang, J., Chen, W. Y., Frank, S. J. (2008). Activation of Growth Hormone Receptors by Growth Hormone and Growth Hormone Antagonist Dimers: Insights into Receptor Triggering. Mol. Endocrinol. 22: 978-988 [Abstract] [Full Text]  
  • Funakoshi-Tago, M., Pelletier, S., Moritake, H., Parganas, E., Ihle, J. N. (2008). Jak2 FERM Domain Interaction with the Erythropoietin Receptor Regulates Jak2 Kinase Activity. Mol. Cell. Biol. 28: 1792-1801 [Abstract] [Full Text]  
  • Swaminathan, G., Varghese, B., Thangavel, C., Carbone, C. J, Plotnikov, A., Kumar, K G S., Jablonski, E. M, Clevenger, C. V, Goffin, V., Deng, L., Frank, S. J, Fuchs, S. Y (2008). Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J Endocrinol 196: R1-R7 [Abstract] [Full Text]  
  • Loesch, K., Deng, L., Wang, X., He, K., Jiang, J., Frank, S. J. (2007). Endoplasmic Reticulum-Associated Degradation of Growth Hormone Receptor in Janus Kinase 2-Deficient Cells. Endocrinology 148: 5955-5965 [Abstract] [Full Text]  
  • Li, Z., Zhou, Y., Carter-Su, C., Myers, M. G. Jr., Rui, L. (2007). SH2B1 Enhances Leptin Signaling by Both Janus Kinase 2 Tyr813 Phosphorylation-Dependent and -Independent Mechanisms. Mol. Endocrinol. 21: 2270-2281 [Abstract] [Full Text]  
  • Asa, S. L., DiGiovanni, R., Jiang, J., Ward, M. L., Loesch, K., Yamada, S., Sano, T., Yoshimoto, K., Frank, S. J., Ezzat, S. (2007). A Growth Hormone Receptor Mutation Impairs Growth Hormone Autofeedback Signaling in Pituitary Tumors. Cancer Res. 67: 7505-7511 [Abstract] [Full Text]  
  • Yang, N., Wang, X., Jiang, J., Frank, S. J. (2007). Role of the Growth Hormone (GH) Receptor Transmembrane Domain in Receptor Predimerization and GH-Induced Activation. Mol. Endocrinol. 21: 1642-1655 [Abstract] [Full Text]  
  • Deng, L., He, K., Wang, X., Yang, N., Thangavel, C., Jiang, J., Fuchs, S. Y., Frank, S. J. (2007). Determinants of Growth Hormone Receptor Down-Regulation. Mol. Endocrinol. 21: 1537-1551 [Abstract] [Full Text]  
  • Orth, J. H. C., Aktories, K., Kubatzky, K. F. (2007). Modulation of Host Cell Gene Expression through Activation of STAT Transcription Factors by Pasteurella multocida Toxin. J. Biol. Chem. 282: 3050-3057 [Abstract] [Full Text]  
  • Frank, S. J., Wang, X., He, K., Yang, N., Fang, P., Rosenfeld, R. G., Hwa, V., Chaudhuri, T. R., Deng, L., Zinn, K. R. (2006). In Vivo Imaging of Hepatic Growth Hormone Signaling. Mol. Endocrinol. 20: 2819-2830 [Abstract] [Full Text]  
  • Mazurkiewicz-Munoz, A. M., Argetsinger, L. S., Kouadio, J.-L. K., Stensballe, A., Jensen, O. N., Cline, J. M., Carter-Su, C. (2006). Phosphorylation of JAK2 at Serine 523: a Negative Regulator of JAK2 That Is Stimulated by Growth Hormone and Epidermal Growth Factor.. Mol. Cell. Biol. 26: 4052-4062 [Abstract] [Full Text]  
  • Loesch, K., Deng, L., Cowan, J. W., Wang, X., He, K., Jiang, J., Black, R. A., Frank, S. J. (2006). Janus Kinase 2 Influences Growth Hormone Receptor Metalloproteolysis. Endocrinology 147: 2839-2849 [Abstract] [Full Text]  
  • Tang, C., Vaughan, A. M., Anantharamaiah, G. M., Oram, J. F. (2006). Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1. J. Lipid Res. 47: 107-114 [Abstract] [Full Text]  
  • He, K., Loesch, K., Cowan, J. W., Li, X., Deng, L., Wang, X., Jiang, J., Frank, S. J. (2005). Janus Kinase 2 Enhances the Stability of the Mature Growth Hormone Receptor. Endocrinology 146: 4755-4765 [Abstract] [Full Text]  
  • Royer, Y., Staerk, J., Costuleanu, M., Courtoy, P. J., Constantinescu, S. N. (2005). Janus Kinases Affect Thrombopoietin Receptor Cell Surface Localization and Stability. J. Biol. Chem. 280: 27251-27261 [Abstract] [Full Text]  
  • Jiang, J., Wang, X., He, K., Li, X., Chen, C., Sayeski, P. P., Waters, M. J., Frank, S. J. (2004). A Conformationally Sensitive GHR [Growth Hormone (GH) Receptor] Antibody: Impact on GH Signaling and GHR Proteolysis. Mol. Endocrinol. 18: 2981-2996 [Abstract] [Full Text]  
  • Wallace, T. A., VonDerLinden, D., He, K., Frank, S. J., Sayeski, P. P. (2004). Microarray analyses identify JAK2 tyrosine kinase as a key mediator of ligand-independent gene expression. Am. J. Physiol. Cell Physiol. 287: C981-C991 [Abstract] [Full Text]  
  • Behrmann, I., Smyczek, T., Heinrich, P. C., Schmitz-Van de Leur, H., Komyod, W., Giese, B., Muller-Newen, G., Haan, S., Haan, C. (2004). Janus Kinase (Jak) Subcellular Localization Revisited: THE EXCLUSIVE MEMBRANE LOCALIZATION OF ENDOGENOUS JANUS KINASE 1 BY CYTOKINE RECEPTOR INTERACTION UNCOVERS THE Jak{middle dot}RECEPTOR COMPLEX TO BE EQUIVALENT TO A RECEPTOR TYROSINE KINASE. J. Biol. Chem. 279: 35486-35493 [Abstract] [Full Text]  
  • Argetsinger, L. S., Kouadio, J.-L. K., Steen, H., Stensballe, A., Jensen, O. N., Carter-Su, C. (2004). Autophosphorylation of JAK2 on Tyrosines 221 and 570 Regulates Its Activity. Mol. Cell. Biol. 24: 4955-4967 [Abstract] [Full Text]  
  • Roberts, J. L., Lengi, A., Brown, S. M., Chen, M., Zhou, Y.-J., O'Shea, J. J., Buckley, R. H. (2004). Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation. Blood 103: 2009-2018 [Abstract] [Full Text]  
  • Chang, Y.-J., Holtzman, M. J., Chen, C.-C. (2004). Differential Role of Janus Family Kinases (JAKs) in Interferon-{gamma}-Induced Lung Epithelial ICAM-1 Expression: Involving Protein Interactions between JAKs, Phospholipase C{gamma}, c-Src, and STAT1. Mol. Pharmacol. 65: 589-598 [Abstract] [Full Text]  
  • Tang, C., Vaughan, A. M., Oram, J. F. (2004). Janus Kinase 2 Modulates the Apolipoprotein Interactions with ABCA1 Required for Removing Cellular Cholesterol. J. Biol. Chem. 279: 7622-7628 [Abstract] [Full Text]  
  • Sandberg, E. M., Ma, X., VonDerLinden, D., Godeny, M. D., Sayeski, P. P. (2004). Jak2 Tyrosine Kinase Mediates Angiotensin II-dependent Inactivation of ERK2 via Induction of Mitogen-activated Protein Kinase Phosphatase 1. J. Biol. Chem. 279: 1956-1967 [Abstract] [Full Text]  
  • He, K., Wang, X., Jiang, J., Guan, R., Bernstein, K. E., Sayeski, P. P., Frank, S. J. (2003). Janus Kinase 2 Determinants for Growth Hormone Receptor Association, Surface Assembly, and Signaling. Mol. Endocrinol. 17: 2211-2227 [Abstract] [Full Text]  
  • Saharinen, P., Vihinen, M., Silvennoinen, O. (2003). Autoinhibition of Jak2 Tyrosine Kinase Is Dependent on Specific Regions in Its Pseudokinase Domain. Mol. Biol. Cell 14: 1448-1459 [Abstract] [Full Text]  
  • Ravandi, F., Talpaz, M., Estrov, Z. (2003). Modulation of Cellular Signaling Pathways: Prospects for Targeted Therapy in Hematological Malignancies. Clin. Cancer Res. 9: 535-550 [Abstract] [Full Text]  
  • Saharinen, P., Silvennoinen, O. (2002). The Pseudokinase Domain Is Required for Suppression of Basal Activity of Jak2 and Jak3 Tyrosine Kinases and for Cytokine-inducible Activation of Signal Transduction. J. Biol. Chem. 277: 47954-47963 [Abstract] [Full Text]  
  • Kloek, C., Haq, A. K., Dunn, S. L., Lavery, H. J., Banks, A. S., Myers, M. G. Jr. (2002). Regulation of Jak Kinases by Intracellular Leptin Receptor Sequences. J. Biol. Chem. 277: 41547-41555 [Abstract] [Full Text]  
  • Lejeune, D., Dumoutier, L., Constantinescu, S., Kruijer, W., Schuringa, J. J., Renauld, J.-C. (2002). Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell Line. PATHWAYS THAT ARE SHARED WITH AND DISTINCT FROM IL-10. J. Biol. Chem. 277: 33676-33682 [Abstract] [Full Text]  
  • Giordanetto, F., Kroemer, R. T. (2002). Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7. Protein Eng Des Sel 15: 727-737 [Abstract] [Full Text]  
  • Chang, Y.-J., Holtzman, M. J., Chen, C.-C. (2002). Interferon-gamma -induced Epithelial ICAM-1 Expression and Monocyte Adhesion. INVOLVEMENT OF PROTEIN KINASE C-DEPENDENT c-Src TYROSINE KINASE ACTIVATION PATHWAY. J. Biol. Chem. 277: 7118-7126 [Abstract] [Full Text]  
  • Yeh, T. C., Dondi, E., Uzé, G., Pellegrini, S. (2000). A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling. Proc. Natl. Acad. Sci. USA 10.1073/pnas.160130297v1 [Abstract] [Full Text]  
  • Pang, Q., Fagerlie, S., Christianson, T. A., Keeble, W., Faulkner, G., Diaz, J., Rathbun, R. K., Bagby, G. C. (2000). The Fanconi Anemia Protein FANCC Binds to and Facilitates the Activation of STAT1 by Gamma Interferon and Hematopoietic Growth Factors. Mol. Cell. Biol. 20: 4724-4735 [Abstract] [Full Text]  
  • Carron, C., Cormier, F., Janin, A., Lacronique, V., Giovannini, M., Daniel, M.-T., Bernard, O., Ghysdael, J. (2000). TEL-JAK2 transgenic mice develop T-cell leukemia. Blood 95: 3891-3899 [Abstract] [Full Text]  
  • Sawka-Verhelle, D., Tartare-Deckert, S., Decaux, J.-F., Girard, J., Van Obberghen, E. (2000). Stat 5B, Activated by Insulin in a Jak-Independent Fashion, Plays a Role in Glucokinase Gene Transcription. Endocrinology 141: 1977-1988 [Abstract] [Full Text]  
  • Saharinen, P., Takaluoma, K., Silvennoinen, O. (2000). Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain. Mol. Cell. Biol. 20: 3387-3395 [Abstract] [Full Text]  
  • Sayeski, P. P., Ali, M. S., Safavi, A., Lyles, M., Kim, S.-O., Frank, S. J., Bernstein, K. E. (1999). A Catalytically Active Jak2 Is Required for the Angiotensin II-dependent Activation of Fyn. J. Biol. Chem. 274: 33131-33142 [Abstract] [Full Text]  
  • Oates, A. C., Brownlie, A., Pratt, S. J., Irvine, D. V., Liao, E. C., Paw, B. H., Dorian, K. J., Johnson, S. L., Postlethwait, J. H., Zon, L. I., Wilks, A. F. (1999). Gene Duplication of Zebrafish JAK2 Homologs Is Accompanied by Divergent Embryonic Expression Patterns: Only jak2a Is Expressed During Erythropoiesis. Blood 94: 2622-2636 [Abstract] [Full Text]  
  • Humphreys, R. C., Hennighausen, L. (1999). Signal Transducer and Activator of Transcription 5a Influences Mammary Epithelial Cell Survival and Tumorigenesis. Cell Growth Differ. 10: 685-694 [Abstract] [Full Text]  
  • Sayeski, P. P., Ali, M. S., Hawks, K., Frank, S. J., Bernstein, K. E. (1999). The Angiotensin II–Dependent Association of Jak2 and c-Src Requires the N-Terminus of Jak2 and the SH2 Domain of c-Src. Circ. Res. 84: 1332-1338 [Abstract] [Full Text]  
  • Richter, M. F., Dumenil, G., Uze, G., Fellous, M., Pellegrini, S. (1998). Specific Contribution of Tyk2 JH Regions to the Binding and the Expression of the Interferon alpha /beta Receptor Component IFNAR1. J. Biol. Chem. 273: 24723-24729 [Abstract] [Full Text]  
  • Leaman, D. W., Salvekar, A., Patel, R., Sen, G. C., Stark, G. R. (1998). A mutant cell line defective in response to double-stranded RNA and in regulating basal expression of interferon-stimulated genes. Proc. Natl. Acad. Sci. USA 95: 9442-9447 [Abstract] [Full Text]  
  • Mikita, T., Daniel, C., Wu, P., Schindler, U. (1998). Mutational Analysis of the STAT6 SH2 Domain. J. Biol. Chem. 273: 17634-17642 [Abstract] [Full Text]  
  • Barahmand-Pour, F., Meinke, A., Groner, B., Decker, T. (1998). Jak2-Stat5 Interactions Analyzed in Yeast. J. Biol. Chem. 273: 12567-12575 [Abstract] [Full Text]  
  • Kanzaki, M., Morris, P. L. (1998). Identification and Regulation of Testicular Interferon-{gamma} (IFN{gamma}) Receptor Subunits: IFN{gamma} Enhances Interferon Regulatory Factor-1 and Interleukin-1{beta} Converting Enzyme Expression. Endocrinology 139: 2636-2644 [Abstract] [Full Text]  
  • Gual, P., Baron, V., Lequoy, V., Van Obberghen, E. (1998). Interaction of Janus Kinases JAK-1 and JAK-2 with the Insulin Receptor and the Insulin-Like Growth Factor-1 Receptor. Endocrinology 139: 884-893 [Abstract] [Full Text]  
  • Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., Bernard, O. A. (1997). A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia. Science 278: 1309-1312 [Abstract] [Full Text]  
  • Gauzzi, M. C., Barbieri, G., Richter, M. F., Uze, G., Ling, L., Fellous, M., Pellegrini, S. (1997). The amino-terminal region of Tyk2 sustains the level of interferon alpha  receptor 1, a component of the interferon alpha /beta  receptor. Proc. Natl. Acad. Sci. USA 94: 11839-11844 [Abstract] [Full Text]  
  • Darnell Jr., J. E. (1997). STATs and Gene Regulation. Science 277: 1630-1635 [Abstract] [Full Text]  
  • Zhang, Y., Guan, R., Jiang, J., Kopchick, J. J., Black, R. A., Baumann, G., Frank, S. J. (2001). Growth Hormone (GH)-induced Dimerization Inhibits Phorbol Ester-stimulated GH Receptor Proteolysis. J. Biol. Chem. 276: 24565-24573 [Abstract] [Full Text]  
  • Sarkar, S., Pollack, B. P., Lin, K.-T., Kotenko, S. V., Cook, J. R., Lewis, A., Pestka, S. (2001). hTid-1, a Human DnaJ Protein, Modulates the Interferon Signaling Pathway. J. Biol. Chem. 276: 49034-49042 [Abstract] [Full Text]  
  • Haan, C., Is'harc, H., Hermanns, H. M., Schmitz-Van de Leur, H., Kerr, I. M., Heinrich, P. C., Grotzinger, J., Behrmann, I. (2001). Mapping of a Region within the N Terminus of Jak1 Involved in Cytokine Receptor Interaction. J. Biol. Chem. 276: 37451-37458 [Abstract] [Full Text]  
  • Yeh, T. C., Dondi, E., Uze, G., Pellegrini, S. (2000). A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling. Proc. Natl. Acad. Sci. USA 97: 8991-8996 [Abstract] [Full Text]